U.S. Virtual Care Market
Get a free sample of this report
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Request Sectional Data
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
The U.S. virtual care market size was estimated at USD 7.1 billion in 2023. The market is expected to grow from USD 8.9 billion in 2024 to USD 69.2 billion in 2032, at a CAGR of 29.2% during the forecast period.
Virtual care refers to telecommunication and digital health platform which provides the consultation and remote healthcare services, allowing the patients to interact with the healthcare provider remotely. The virtual care includes a board range of services such as telehealth, which is estimated to reach USD 244 billion by 2032, telemedicine, mobile health application, and remote patient monitoring.
Report Attribute | Details |
---|---|
Base Year: | 2024 |
U.S. Virtual Care Market Size in 2024: | USD 7.1 Billion |
Forecast Period: | 2025 - 2034 |
Forecast Period 2023 - 2032 CAGR: | 29.2 |
2023 Value Projection: | USD 69.2 Billion |
Historical Data for: | 2021 - 2024 |
No of Pages: | 78 |
Tables, Charts & Figures: | 68 |
Segments Covered: | Service Type, Delivery Mode, Application, and End Use |
Growth Drivers: |
|
Pitfalls Challenges: |
|
The growth of the market is highly attributed due to the rising prevalence of chronic disease in the country such as cancer, cardiovascular diseases, neurological diseases, diabetes, among others. For instance, as per the data from the American Cancer Society in 2025, around 2,041,910 new cases of cancer are to be diagnosed, and 618,120 cases of cancer related deaths are projected to occur in the U.S.
Furthermore, according to the U.S. Centers for Disease Control and Prevention (CDC), heart disease is the major cause of the death among the individuals in the U.S. In 2022, around 702,880 individuals in the U.S. had lost their lives due to heart disease, which is equivalent to 1 in 5 deaths in the U.S. Therefore, patients with these conditions require frequent follow up with the specialists such as the oncologist, cardiologist, neurologist, among others. Virtual care solution enables continuous remote monitoring of these patients, which allows the healthcare providers to track the parameters such as the heart rate, vital levels, blood glucose level and medication adherence of patient with chronic diseases conditions.
Moreover, virtual care reduces the need of hospital visits, facilitates early interventions, reduces the waiting time of the patients, overcome geographical barrier, and the cost that are associated with patient visits to hospitals. Thus, the benefits offered by the virtual care is anticipated to propel the market growth in the country.
Additionally, continuous innovation in the field of healthcare IT is a significant catalyst for the growth of the market in the country. Innovations such AI, cloud computing, blockchain, and big data analytics are propelling the efficacy and efficiency of the virtual care services. Moreover, the integration of electronic health records (EHR) with these virtual care platforms such as telemedicine, enables the healthcare providers to access the patient’s history, which help the physicians to provide accurate and appropriate diagnosis and treatment plan to the patients, thereby stimulating the adoption of these services among the patients and healthcare providers accelerating the market growth.
Based on service type, the market is bifurcated into telehealth, telemedicine, and remote patient monitoring. The market was estimated at USD 7.1 billion in 2023. The telehealth segment held revenue of USD 3 billion in 2023 and the segment is poised for significant growth at a CAGR of 29.4% during the forecast period.
Based on delivery mode, the U.S. virtual care market is segmented into synchronous virtual care and asynchronous virtual care. The synchronous virtual care segment dominated the market and was valued at USD 5.1 billion in 2023 with a revenue share of 72.5%.
Based on application, the U.S. virtual care market is segmented into cardiology, gynecology, neurology, orthopedics, dermatology, mental health, and other applications. The growth of dermatology segment in the market projected to reach USD 20.2 billion by 2032.
Based on end use, the U.S. virtual care market is bifurcated into payers, providers, patients, and other end users. The providers segment held the largest revenue of USD 3 billion in 2023.
The top 4 players of the market account for approximately 40% of the market share which includes companies such as American Well Corporation, Teladoc Health, CVS Health Corporation, and UnitedHealth Group. A crucial aspect of market strategy involves the frequent introduction of innovations such as high-definition video, AI-powered diagnostic tools, and seamless integration with electronic health records (EHRs). Moreover, strategic partnerships with hospitals, healthcare providers, research institutes, and government agencies play a primary role in advancing the development of new services, technologies and getting the necessary permits, enabling market players to strengthen their position in this growing sector.
Some of the eminent market participants operating in the U.S. virtual care industry include:
Market, By Service Type
Market, By Delivery Mode
Market, By Application
Market, By End Use
The U.S. virtual care industry was valued at USD 7.1 billion in 2023 and is projected to grow from USD 8.9 billion in 2024 to USD 69.2 billion by 2032, at a CAGR of 29.2% during the forecast period.
The synchronous virtual care segment was valued at USD 5.1 billion in 2023, accounting for a 72.5% revenue share.
Some of the prominent players in the market include American Well Corporation, AMD Global Telemedicine, CareClix, CVS Health Corporation, Included Health, HealthTap, iCliniq, and Koninklijke Philips N.V.
The dermatology segment is expected to reach USD 20.2 billion by 2032.